Heterogeneous to the two most common subtypes of lung adenocarcinoma and squamous cell carcinoma in NSCLC, driver mutations, primarily KRAS and MET mutations, may be intrinsic drivers of the malignant features of PSC (24–26). The gene discussed is MET; the disease is lung adenocarcinoma.